intended for adults with mild memory loss associated with aging. Users take just one daily pill, which are sold in both regular and extra strength. A chewable is available, too.
The participants took a battery of tests that evaluated various aspects of cognition related to memory. When researchers compared their initial results with those after three months on the pills, they found that subgroups including around 100 people with normal cognitive aging or very mild cognitive impairment improved significantly more on apoaequorin than on a placebo.
"The interest in self-care continues to be strong and OTC products play a key role in people’s focus on managing their own well-being," Pharmacy Times Vice President Gil Hernandez . "The OTC Guide gives consumers a trustworthy resource to support their self-care, as pharmacists themselves are among our most relied upon healthcare professionals."